MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET
|
0.740 |
GeneticVariation
|
disease |
UNIPROT |
Mutations in the satellite cell gene MEGF10 cause a recessive congenital myopathy with minicores.
|
22371254 |
2012 |
MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET
|
0.740 |
GeneticVariation
|
disease |
UNIPROT |
Mutations in MEGF10, a regulator of satellite cell myogenesis, cause early onset myopathy, areflexia, respiratory distress and dysphagia (EMARDD).
|
22101682 |
2011 |
MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET
|
0.740 |
GeneticVariation
|
disease |
CLINVAR |
Mutations in MEGF10, a regulator of satellite cell myogenesis, cause early onset myopathy, areflexia, respiratory distress and dysphagia (EMARDD).
|
22101682 |
2011 |
MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET
|
0.740 |
GeneticVariation
|
disease |
UNIPROT |
Cysteine mutations cause defective tyrosine phosphorylation in MEGF10 myopathy.
|
23954233 |
2013 |
MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET
|
0.740 |
GeneticVariation
|
disease |
UNIPROT |
Megf10 regulation of myoblast function appears to be mediated at least in part via interactions with key components of the Notch signaling pathway, and defects in these interactions may contribute to the pathogenesis of EMARDD.
|
28498977 |
2017 |
MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET
|
0.740 |
GeneticVariation
|
disease |
BEFREE |
By novel analysis of SNP array hybridization and exome sequence coverage, we diagnosed a 10-years old girl with EMARDD following identification of a novel homozygous deletion of exon 7 in MEGF10.
|
23453856 |
2013 |
MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET
|
0.740 |
GeneticVariation
|
disease |
UNIPROT |
Our studies reveal that Megf10 is a receptor for C1q and identify a novel role for Megf10 in clearance of apoptotic cells in the mammalian developing brain with potential relevance to EMARDD patients and other CNS disorders.
|
27170117 |
2016 |
MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET
|
0.740 |
GeneticVariation
|
disease |
CLINVAR |
Mutations in the satellite cell gene MEGF10 cause a recessive congenital myopathy with minicores.
|
22371254 |
2012 |
MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET
|
0.740 |
GeneticVariation
|
disease |
CLINVAR |
Cysteine mutations cause defective tyrosine phosphorylation in MEGF10 myopathy.
|
23954233 |
2013 |
MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET
|
0.740 |
GeneticVariation
|
disease |
BEFREE |
We here present two Japanese patients with MEGF10 mutations: one with EMARDD phenotype who had a novel homozygous frameshift mutation, c.131_132del, and the other with the milder phenotype who harbored a compound heterozygous mutation, c.2981-2A > G, and a novel missense mutation, p.Cys810Tyr.
|
27460346 |
2016 |
MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET
|
0.740 |
GeneticVariation
|
disease |
CLINVAR |
By novel analysis of SNP array hybridization and exome sequence coverage, we diagnosed a 10-years old girl with EMARDD following identification of a novel homozygous deletion of exon 7 in MEGF10.
|
23453856 |
2013 |
Deglutition Disorders
|
0.450 |
GeneticVariation
|
group |
BEFREE |
Mutations in MEGF10 cause early onset myopathy, areflexia, respiratory distress, and dysphagia (EMARDD), a rare congenital muscle disease, but the pathogenic mechanisms remain largely unknown.
|
28498977 |
2017 |
Deglutition Disorders
|
0.450 |
GeneticVariation
|
group |
BEFREE |
Multiple EGF-like domains 10 (Megf10) is a class F scavenger receptor (SR-F3) expressed on astrocytes and myosatellite cells, and recessive mutations in humans result in early-onset myopathy, areflexia, respiratory distress, and dysphagia (EMARDD).
|
27170117 |
2016 |
Deglutition Disorders
|
0.450 |
GeneticVariation
|
group |
BEFREE |
Novel SNP array analysis and exome sequencing detect a homozygous exon 7 deletion of MEGF10 causing early onset myopathy, areflexia, respiratory distress and dysphagia (EMARDD).
|
23453856 |
2013 |
Deglutition Disorders
|
0.450 |
GeneticVariation
|
group |
BEFREE |
Mutations in the multiple epidermal growth factor-like domains 10 (MEGF10: NM_032446.2) gene are known to cause early-onset myopathy characterized by areflexia, respiratory distress, and dysphagia (EMARDD: OMIM 614399), and a milder phenotype of minicore myopathy.
|
27460346 |
2016 |
Schizophrenia
|
0.410 |
GeneticVariation
|
disease |
GWASCAT |
Five novel loci associated with antipsychotic treatment response in patients with schizophrenia: a genome-wide association study.
|
29503163 |
2018 |
Myopathy
|
0.400 |
GeneticVariation
|
group |
BEFREE |
Mutations in MEGF10 cause early onset myopathy, areflexia, respiratory distress, and dysphagia (EMARDD), a rare congenital muscle disease, but the pathogenic mechanisms remain largely unknown.
|
28498977 |
2017 |
Myopathy
|
0.400 |
GeneticVariation
|
group |
BEFREE |
Multiple EGF-like domains 10 (Megf10) is a class F scavenger receptor (SR-F3) expressed on astrocytes and myosatellite cells, and recessive mutations in humans result in early-onset myopathy, areflexia, respiratory distress, and dysphagia (EMARDD).
|
27170117 |
2016 |
Myopathy
|
0.400 |
GeneticVariation
|
group |
BEFREE |
Our analysis of drpr mutant flies revealed muscle degeneration with fiber size variability and vacuolization, as well as reduced motor performance, features that have been observed in human MEGF10 myopathy.
|
25111228 |
2014 |
Myopathy
|
0.400 |
GeneticVariation
|
group |
BEFREE |
Screening the MEGF10 open reading frame in 190 patients with genetically unexplained myopathies revealed a heterozygous mutation, c.211C > T (p.R71W), in one additional subject with a similar clinical and histological presentation as the discovery family.
|
22371254 |
2012 |
Myopathy
|
0.400 |
GeneticVariation
|
group |
BEFREE |
MEGF10 mutations can cause myopathy with adult-onset respiratory insufficiency.
|
26802438 |
2016 |
Myopathy
|
0.400 |
GeneticVariation
|
group |
BEFREE |
Novel SNP array analysis and exome sequencing detect a homozygous exon 7 deletion of MEGF10 causing early onset myopathy, areflexia, respiratory distress and dysphagia (EMARDD).
|
23453856 |
2013 |
Alzheimer's Disease
|
0.120 |
GeneticVariation
|
disease |
GWASDB |
Genome-wide association study of the rate of cognitive decline in Alzheimer's disease.
|
23535033 |
2014 |
Alzheimer's Disease
|
0.120 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association study of the rate of cognitive decline in Alzheimer's disease.
|
23535033 |
2014 |
Respiratory distress
|
0.120 |
GeneticVariation
|
phenotype |
BEFREE |
Early-onset myopathy, areflexia, respiratory distress and dysphagia (EMARDD) is a myopathic disorder associated with mutations in MEGF10.
|
23453856 |
2013 |